Reuters logo
BRIEF-Tigenix provides update on Cx601 marketing authorization application procedure in Europe
March 6, 2017 / 6:15 AM / 7 months ago

BRIEF-Tigenix provides update on Cx601 marketing authorization application procedure in Europe

March 6 (Reuters) - Tigenix Nv:

* Tigenix provides update on Cx601 marketing authorization application procedure in Europe

* Announces that it has received Day 180 List Of Outstanding Issues (LOOI) from Committee for Medicinal Products for Human Use (CHMP) of European Medicines Agency (EMA)

* Expects to receive a marketing authorization decision for Cx601 in 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below